MARKSANS PHARMA LTD. - 524404 - Board Meeting Intimation for Notice Of Board Meeting
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2021 ,inter alia, to consider and approve Unaudited Financial Results of the Company (both Standalone and Consolidated) for the Quarter ended 31st December, 2020. MARKSANS PHARMA LTD. - 524404 - Shareholding for the Period Ended December 31, 2020
Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here MARKSANS PHARMA LTD. - 524404 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December, 2020 received from Bigshare Services Private Limited, Registrar and Transfer Agent of the Company. MARKSANS PHARMA LTD. - 524404 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Harshavardhan PanigrahiDesignation :- Company Secretary and Compliance Officer MARKSANS PHARMA LTD. - 524404 - Closure of Trading Window
In terms of the Company's Code of Conduct to Regulate, Monitor and Report Trading by designated persons framed pursuant to SEBI (Prohibition of Insider Trading)(Amendment) Regulations, 2018, the trading window for dealing in the securities of Marksans Pharma Limited (the Company) for the insiders of the Company will remain closed with effect from Friday, 1st January, 2021 till 48 hours after the declaration of financial results for the quarter ended 31st December, 2020. The date of declaration of financial results will be intimated separately in due course of time. MARKSANS PHARMA LTD. - 524404 - Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2020.
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith disclosures of related party transactions for the half year ended 30th September, 2020. The financial results for the quarter and half year ended 30th September, 2020 both standalone and consolidated were published on 6th November, 2020. MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find attached an investors presentation of Marksans Pharma Limited for Q2&H1; FY21. MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Enclosed herewith kindly find a News Release dated 6th November, 2020 of the Company.